These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
667 related items for PubMed ID: 19264847
1. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity. Yu L, Wu WK, Li ZJ, Liu QC, Li HT, Wu YC, Cho CH. Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847 [Abstract] [Full Text] [Related]
2. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression. Ye CG, Wu WK, Yeung JH, Li HT, Li ZJ, Wong CC, Ren SX, Zhang L, Fung KP, Cho CH. Cancer Lett; 2011 May 28; 304(2):90-6. PubMed ID: 21377266 [Abstract] [Full Text] [Related]
3. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation. Yu L, Chen M, Li Z, Wen J, Fu J, Guo D, Jiang Y, Wu S, Cho CH, Liu S. Mol Pharmacol; 2011 Mar 28; 79(3):608-17. PubMed ID: 21177414 [Abstract] [Full Text] [Related]
4. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K. Int J Oncol; 2003 Sep 28; 23(3):665-72. PubMed ID: 12888902 [Abstract] [Full Text] [Related]
5. Lipopolysaccharide induces epithelium- and prostaglandin E(2)-dependent relaxation of mouse isolated trachea through activation of cyclooxygenase (COX)-1 and COX-2. Balzary RW, Cocks TM. J Pharmacol Exp Ther; 2006 May 28; 317(2):806-12. PubMed ID: 16464966 [Abstract] [Full Text] [Related]
6. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line. Nishanth RP, Ramakrishna BS, Jyotsna RG, Roy KR, Reddy GV, Reddy PK, Reddanna P. Eur J Pharmacol; 2010 Dec 15; 649(1-3):74-83. PubMed ID: 20858479 [Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo. Zrieki A, Farinotti R, Buyse M. Eur J Pharmacol; 2010 Jun 25; 636(1-3):189-97. PubMed ID: 20361960 [Abstract] [Full Text] [Related]
8. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells. Lampiasi N, Foderà D, D'Alessandro N, Cusimano A, Azzolina A, Tripodo C, Florena AM, Minervini MI, Notarbartolo M, Montalto G, Cervello M. Int J Mol Med; 2006 Feb 25; 17(2):245-52. PubMed ID: 16391822 [Abstract] [Full Text] [Related]
9. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Shin YK, Park JS, Kim HS, Jun HJ, Kim GE, Suh CO, Yun YS, Pyo H. Cancer Res; 2005 Oct 15; 65(20):9501-9. PubMed ID: 16230415 [Abstract] [Full Text] [Related]
10. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B. J Oral Pathol Med; 2004 Nov 15; 33(10):607-13. PubMed ID: 15482327 [Abstract] [Full Text] [Related]
13. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. Mazzanti R, Platini F, Bottini C, Fantappiè O, Solazzo M, Tessitore L. Biochem Pharmacol; 2009 Jul 01; 78(1):21-32. PubMed ID: 19447220 [Abstract] [Full Text] [Related]
14. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Arunasree KM, Roy KR, Anilkumar K, Aparna A, Reddy GV, Reddanna P. Leuk Res; 2008 Jun 01; 32(6):855-64. PubMed ID: 18083230 [Abstract] [Full Text] [Related]
15. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells. Ferrera P, Arias C. Neurochem Int; 2005 Dec 01; 47(8):589-96. PubMed ID: 16169124 [Abstract] [Full Text] [Related]
16. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin. Narang VS, Pauletti GM, Gout PW, Buckley DJ, Buckley AR. Chemotherapy; 2007 Dec 01; 53(3):210-7. PubMed ID: 17356269 [Abstract] [Full Text] [Related]
17. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD. Cancer Res; 2000 Jun 01; 60(11):2964-72. PubMed ID: 10850444 [Abstract] [Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs. Angelini A, Iezzi M, Di Febbo C, Di Ilio C, Cuccurullo F, Porreca E. Oncol Rep; 2008 Oct 01; 20(4):731-5. PubMed ID: 18813811 [Abstract] [Full Text] [Related]
19. CC 05, a novel anti-inflammatory compound, exerts its effect by inhibition of cyclooxygenase-2 activity. Yin LL, Zhang WY, Li MH, Shen JK, Zhu XZ. Eur J Pharmacol; 2005 Sep 27; 520(1-3):172-8. PubMed ID: 16168408 [Abstract] [Full Text] [Related]
20. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. Cancer Lett; 2008 Jan 18; 259(1):111-8. PubMed ID: 18006147 [Abstract] [Full Text] [Related] Page: [Next] [New Search]